Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia

Annals of Clinical Biochemistry

Volumn 51, Issue 4, 2014, Pages 485-489

  Hooper, Amanda J ^a,b,c   Kurtkoti, Jagadeesh ^d   Hamilton Craig, Ian ^d   Burnett, John R ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

ApoA V; apoC II; hypertriglyceridaemia; lipoprotein lipase; primary chylomicronaemia

Indexed keywords

ACETYLSALICYLIC ACID; APOENZYME; ATORVASTATIN; CANDESARTAN; FENOFIBRATE; GEMFIBROZIL; HEMOGLOBIN A1C; INSULIN; LIPOPROTEIN LIPASE; METFORMIN; MOXONIDINE; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; ROSUVASTATIN; SPIRONOLACTONE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; APOLIPOPROTEIN C2;

ABDOMINAL AORTA ANEURYSM; ACUTE PANCREATITIS; ADULT; AGED; ANGIOPLASTY; APOA5 GENE; APOC2 GENE; ARTICLE; AXONAL NEUROPATHY; BLURRED VISION; BODY MASS; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIET RESTRICTION; DISEASE SEVERITY; DRUG EFFECT; DRUG WITHDRAWAL; ECHOGRAPHY; EPIGASTRIC PAIN; EXON; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HEART SIZE; HEPATOSPLENOMEGALY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY ARTERY STENOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; LOW DRUG DOSE; MIDDLE AGED; MUSCLE DISEASE; MYALGIA; NEUROPATHY; NEWBORN JAUNDICE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONSENSE MUTATION; PARESTHESIA; PERITONEAL FLUID; PLASMAPHERESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINUS RHYTHM; SPLENOMEGALY; STENT; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VOMITING; WEAKNESS; BLOOD; GENETICS; MALE; MUTATION; PATHOLOGY;

ADULT; AGED; APOLIPOPROTEIN C-II; APOLIPOPROTEINS A; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MALE; MUTATION;

EID: 84902163746     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563214525767     Document Type: Article

References (17)

1. Yuan G,Al-Shali KZ,Hegele RA.Hypertriglyceridemia: its etiology, effects and treatment.CMAJ. 2007;176:1113-1120.
2. Hokanson JE,Austin MA.Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.J Cardiovasc Risk. 1996;3:213-219.
3. Toskes PP.Hyperlipidemic pancreatitis.Gastroenterol Clin North Am. 1990;19:783-791.
4. Murad MH,Hazem A,Coto-Yglesias Fet al.The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis.BMC Endocrine Disord. 2012;12:2-2.
5. Merkel M,Eckel RH,Goldberg IJ.Lipoprotein lipase: genetics, lipid uptake, and regulation.J Lipid Res. 2002;43:1997-2006.
6. Brunzell JD,Deeb SSThe metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001, pp. 2789-2816.Scriver CRBeaudet ALSly WSValle DChilds BKinzler K, ed. New York: McGraw-Hill; 2001:2789-2816.
7. Rahalkar AR,Giffen F,Har Bet al.Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review.Can J Physiol Pharmacol. 2009;87:151-160.
8. Sharma V,Forte TM,Ryan RO.Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.Curr Opin Lipidol. 2013;24:153-159.
9. Johansen CT,Hegele RA.Genetic bases of hypertriglyceridemic phenotypes.Curr Opin Lipidol. 2011;22:247-253.
10. Benlian P,De Gennes JL,Foubert Let al.Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.N Engl J Med. 1996;335:848-854.
11. Emi M,Wilson DE,Iverius PHet al.Missense mutation (Gly-Glu188) of human lipoprotein lipase imparting functional deficiency.J Biol Chem. 1990;265:5910-5916.
12. Priore Oliva C,Carubbi F,Schaap FGet al.Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene.J Intern Med. 2008;263:450-458.
13. Sun G,Bi N,Li Get al.Identification of lipid binding and lipoprotein lipase activation domains of human apoAV.Chem Phys Lipids. 2006;143:22-28.
14. Mendoza-Barbera E,Julve J,Nilsson SKet al.Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.J Lipid Res. 2013;54:649-661.
15. Wang J,Ban MR,Zou GYet al.Polygenic determinants of severe hypertriglyceridemia.Hum Mol Genet. 2008;17:2894-2899.
16. Walden CC,Hegele RA.Apolipoprotein E in hyperlipidemia.Ann Intern Med. 1994;120:1026-1036.
17. Goldberg AS,Hegele RA.Severe hypertriglyceridemia in pregnancy.J Clin Endocrinol Metab. 2012;97:2589-2596.